US Patent Issued to Board of Regents, The University of Texas System on July 7 for "Engineered T cell receptors and methods of use" (Texas Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,980, issued on July 7, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Engineered T cell receptors and methods of use" was invented by Cassian Yee (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides for engineered T cell Receptors (TCRs), cells comprising the TCRs, and methods of making and using the TCRs. The current disclosure relates to TCRs that specifically recognize gp100. Accordingly, aspects of the disclosure relate to an engineered T-cell Receptors (TCRs), nucleic acids encoding the TCRs, and cells comprising the nucleic acids and TCRs. Also provided are compositions comprising ...